Inactive Instrument

Highlights Kadmon Holdings, Inc.

Equities

KDMN

US48283N1063

Highlights

Unlock all the news: Be the first to know and act before the market!

Sanofi in $1 bln deal to buy U.S.-based Amunix Pharma	21-12-21	RE
Sanofi Closes on Kadmon Acquisition	21-11-09	MT
Sanofi completed the acquisition of Kadmon Holdings, Inc..	21-11-08	CI
Kadmon Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-04	CI
Earnings Flash (KDMN) KADMON HOLDINGS Reports Q3 Revenue $14.7M	21-11-04	MT
Kadmon : Announces Expiration of HSR Waiting Period in Sanofi Deal	21-10-21	MT
KADMON : Oppenheimer Suspends Rating for Kadmon Holdings Following Sanofi Merger	21-09-09	MT
Top Midday Gainers	21-09-08	MT
Kadmon Shares Rise 72% After Sanofi Bid of $9.50 a Share	21-09-08	DJ
Kadmon Holdings Shares Jump 77% Premarket After Sanofi Buyout Offer	21-09-08	DJ
Sanofi : Continues M&A Spree With $1.9 Billion Takeover of Transplant Drug Maker Kadmon	21-09-08	MT
Sanofi : to Buy Kadmon in $1.9 Billion All-Cash Deal	21-09-08	MT
Sanofi : To Boost Transplant Business With $1.9 Billion Kadmon Acquisition	21-09-08	MT
Sanofi to Acquire U.S. Biopharmaceutical Company Kadmon	21-09-07	DJ
Sanofi made a non-binding indication of interest to acquire Kadmon Holdings, Inc. for $1.6 billion.	21-09-07	CI
Kadmon : Says Rezurock Drug Now Available for Patients with Chronic Graft-Versus-Host Disease	21-08-19	MT
Kadmon Holdings, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-05	CI
Kadmon : Earnings Flash (KDMN) KADMON HOLDINGS Posts Q2 Revenue $197,000	21-08-05	MT
Kadmon Holdings, Inc Announces U.S. Food and Drug Administration Approval of Rezurock (Belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease	21-07-19	CI
Kadmon : Earnings Flash (KDMN) KADMON HOLDINGS Posts Q1 Revenue $563,000	21-05-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kadmon Holdings, Inc.

Equities

KDMN

US48283N1063

Highlights

Filters